INVANZ 1 GM VIAL

ertapenem sodium
$122.4190per EA
High Outlier

Strength

1 g/1

NDC

00006384371

Classification

Brand

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

1/5/2018

Active Ingredients

ERTAPENEM SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021337

On Market Since

11/21/2001

Pharmacological Classes

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+85.5%

Related Drugs

Same classification

No related drugs found.